위원회 위원명단 - 대한내과학회

eluting stent with a standard stent for coronary revascularization. N Engl J Med
2002;346:1773-80.
13. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment
of patients with long atherosclerotic lesions in small coronary arteries: doubleblind,
randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
14. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results
from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for
de novo coronary lesions. Circulation 2003;107:38-42.
15. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness
of slow- and moderate-release polymer-based paclitaxel-eluting stents for
coronary artery lesions. Circulation 2003;108:788-94.
16. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: in-stent restenosis treated
with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
Circulation 2003;107:559-64.
17. Lansky AJ, Costa RA, Mintz GS, et al. Non-polymer-based paclitaxel-coated coronary
stents for the treatment of patients with de novo coronary lesions: angiographic
follow-up of the DELIVER clinical trial. Circulation 2004;109:1948-54.
18. Gershlick A, De Scheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting,
polymer-free coronary stent: the European evaLUation of pacli-
Taxel Eluting Stent (ELUTES) trial. Circulation 2004;109:487-93.
19. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in
the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard
stent in patients at high risk for coronary restenosis. Circulation 2004;109:634-40.
20. Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release,
polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation
2004;109:1942-7.
21. Kastrati A, Mehilli J, Schlotterbeck K, et al. Early administration of reteplase plus
abciximab vs abciximab alone in patients with acute myocardial infarction referred
for percutaneous coronary intervention: a randomized controlled trial. JAMA 2004;
291:947-54.
22. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus-eluting stents to
prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-70.
23. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting
stents for coronary revascularization. N Engl J Med 2005;353:653-62.
24. Goy JJ, Stauffer JC, Siegenthaler M, Benoit A, Seydoux C. A prospective randomized
comparison between paclitaxel and sirolimus stents in the real world of interventional
cardiology: the TAXi trial. J Am Coll Cardiol 2005;45:308-11.
25. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxeleluting
stent with a bare metal stent in patients with complex coronary artery disease:
a randomized controlled trial. JAMA 2005;294:1215-23.
26. Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting
stents in the treatment of complex, long coronary artery lesions from
a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary
clinical practice. Circulation 2005;112:3306-13.
27. Morice MC, Colombo A, Meier B, et al. Sirolimus-vs paclitaxel-eluting stents in
de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
JAMA 2006;295:895-904.
관동맥 확장성형술의 개정판
33